Of the 52 patients initially enrolled, two patients from the
experimental group were excluded because they did not enter
information on the website for more than four weeks.
Although these two patients were assessed in the post-test
for ethical consideration, their test results were not used in
data analysis. Also, two patients were excluded from the
control group as a result of unwillingness to complete the
study (attrition rate: 7Æ7). Therefore, the data analysis was
performed on 48 patients. Slightly more than half of the
participants were women (57%). The age range of the
patients was 18–39 years, and mean age was 23Æ35 years.
Almost all participants (97%) had type 1 diabetes. The
results for different metabolic control indicators are shown in
Table 3. In the experimental group, mean average HbA1C
decreased significantly from 9Æ10% at the beginning of the
intervention to 7Æ07% after twelve weeks (p < 0Æ001). Mean
LDL decreased significantly from 103Æ04 mg/dl at the beginning
of the intervention to 94Æ83 mg/dl after twelve weeks
(p < 0Æ04). Mean HDL increased significantly from 40 mg/dl
at the beginning of the intervention to 45Æ58 mg/dl after
twelve weeks (p < 0Æ029). In the control group, HDL
increased significantly, but there were no significant changes
in the other variables. According to t-tests for independent
samples, the mean changes in indicators differed significantly
between groups for HbA1C and LDL.
Of the 52 patients initially enrolled, two patients from theexperimental group were excluded because they did not enterinformation on the website for more than four weeks.Although these two patients were assessed in the post-testfor ethical consideration, their test results were not used indata analysis. Also, two patients were excluded from thecontrol group as a result of unwillingness to complete thestudy (attrition rate: 7Æ7). Therefore, the data analysis wasperformed on 48 patients. Slightly more than half of theparticipants were women (57%). The age range of thepatients was 18–39 years, and mean age was 23Æ35 years.Almost all participants (97%) had type 1 diabetes. Theresults for different metabolic control indicators are shown inTable 3. In the experimental group, mean average HbA1Cdecreased significantly from 9Æ10% at the beginning of theintervention to 7Æ07% after twelve weeks (p < 0Æ001). MeanLDL decreased significantly from 103Æ04 mg/dl at the beginningof the intervention to 94Æ83 mg/dl after twelve weeks(p < 0Æ04). Mean HDL increased significantly from 40 mg/dlat the beginning of the intervention to 45Æ58 mg/dl aftertwelve weeks (p < 0Æ029). In the control group, HDLincreased significantly, but there were no significant changesin the other variables. According to t-tests for independentsamples, the mean changes in indicators differed significantlybetween groups for HbA1C and LDL.
การแปล กรุณารอสักครู่..